Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease

BACKGROUND: Fluoroquinolones are often used for the treatment of refractory Mycobacterium avium complex (MAC) disease when the clinical efficacy of the recommended regimen, which includes clarithromycin (CAM), rifampicin (RFP), and ethambutol (EB), is insufficient. However, recent in vitro and in vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimomura, Hitoshi, Ono, Airi, Imanaka, Keiko, Majima, Toru, Masuyama, Hidenori, Sato, Tsugumichi, Aoyama, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728750/
https://www.ncbi.nlm.nih.gov/pubmed/26819735
http://dx.doi.org/10.1186/s40780-015-0025-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728750/
https://www.ncbi.nlm.nih.gov/pubmed/26819735
http://dx.doi.org/10.1186/s40780-015-0025-4

Ejemplares similares